Company launched by MD Anderson to be acquired by Abbott
IDEV Technologies¡¯ next-generation stent technology attracts bid by industry leader
MD Anderson News Release 07/24/13
A private company based on technology discovered at Â鶹ӳ» MD Anderson agreed last week to be purchased by Abbott Laboratories, Inc., for $310 million.
IDEV Technologies, Inc., of Webster, Texas, has developed an innovative stent system to treat blockages in blood vessels...
From Prevention to Survivorship: The Obesity-Cancer Challenge
MD Anderson Backgrounder 07/19/13
With growing understanding of the links between obesity and cancer,? MD Anderson Cancer Center...UT MD Anderson repeats as nation¡¯s top hospital for cancer in annual survey
MD Anderson News Release 07-16-13
Â鶹ӳ» MD Anderson Cancer CenterAccording to the U.S. News & World Report¡¯s...
Study shows African-American chronic lymphocytic leukemia patients don¡¯t survive as long as others who receive similar treatment
UT MD Anderson, Duke researchers find blacks are treated quicker, have more advanced disease
MD Anderson News Release 07/11/13
African-Americans with chronic lymphocytic leukemia who receive standard treatments respond initially as well as non-African-Americans, yet do not survive as long, researchers report in a paper published online this week in CANCER, a journal of the American Cancer Society.
¡°°Õ³ó±ð²õ±ð...
Researchers pinpoint sources of fibrosis-promoting cells that ravage organs
Four pathways lead to creation of myofibroblasts that cause destructive runaway scarring
MD Anderson News Release 07/01...